Yoshihiro Kawaoka
Affiliations: | University of Tennessee Health Science Center, Memphis, TN, United States |
Area:
Molecular Biology, MicrobiologyGoogle:
"Yoshihiro Kawaoka"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Fan S, Kong H, Babujee L, et al. (2024) Assessment of the antigenic evolution of a clade 6B.1 human H1N1pdm influenza virus revealed differences between ferret and human convalescent sera. Ebiomedicine. 101: 105013 |
| Halfmann PJ, Loeffler K, Duffy A, et al. (2024) Broad protection against clade 1 sarbecoviruses after a single immunization with cocktail spike-protein-nanoparticle vaccine. Nature Communications. 15: 1284 |
| Hagihara M, Hayashi H, Nakashima S, et al. (2024) Clinical Efficacy of Imdevimab/Casirivimab for Persistent Omicron SARS-CoV-2 Infection in Patients with Hematological Malignancies. Internal Medicine (Tokyo, Japan) |
| Uraki R, Kiso M, Iwatsuki-Horimoto K, et al. (2023) Characterization of a SARS-CoV-2 EG.5.1 clinical isolate in vitro and in vivo. Cell Reports. 42: 113580 |
| Uraki R, Ito M, Kiso M, et al. (2023) Antiviral efficacy against and replicative fitness of an XBB.1.9.1 clinical isolate. Iscience. 26: 108147 |
| Maemura T, Guan L, Gu C, et al. (2023) Characterization of highly pathogenic clade 2.3.4.4b H5N1 mink influenza viruses. Ebiomedicine. 97: 104827 |
| Kikuchi C, Antonopoulos A, Wang S, et al. (2023) Glyco-engineered MDCK cells display preferred receptors of H3N2 influenza absent in eggs used for vaccines. Nature Communications. 14: 6178 |
| Chiba S, Halfmann PJ, Iida S, et al. (2023) Recombinant spike protein vaccines coupled with adjuvants that have different modes of action induce protective immunity against SARS-CoV-2. Vaccine |
| Guan L, Ping J, Lopes TJS, et al. (2023) Development of an Enhanced High-Yield Influenza Vaccine Backbone in Embryonated Chicken Eggs. Vaccines. 11 |
| Kuroda M, Halfmann PJ, Thackray LB, et al. (2023) An antiviral role for TRIM14 in Ebola virus infection. The Journal of Infectious Diseases |